| The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Patent applications |
| Patent application number | Title | Published |
|---|
| 20120101411 | AUTOMATED NEAR-FALL DETECTOR - A method of gait data collection, the method comprising collecting movement data, determining from the data a movement parameter that includes a third order derivative of position, comparing the movement parameter with a threshold value, and counting at least a near fall if the movement parameter exceeds the threshold value. | 04-26-2012 |
| 20120041544 | STENT GRAFT FENESTRATION - A method of deploying a stent graft in a blood vessel with at least one side branch vessel, comprising: (a) forming a blood flow conduit between the branch vessel and the blood vessel such that a vessel section of the conduit is axially located inside the blood vessel and a branch section is positioned inside the branch vessel; (b) deploying the stent graft inside the blood vessel so that blood flow into said at least one side branch is blocked by the stent graft and continues through the blood flow conduit; (c) forming an opening suitable for allowing blood flow between the blood vessel and the branch vessel; and (d) interrupting blood flow in the vessel section of the conduit. | 02-16-2012 |
| 20110230955 | EXTERNAL STENT - An external vein support comprising an elongate axial body including an axis, said body is plastically deformable by at least one of stretching, bending, twisting, and any combination thereof, relative to said axis. | 09-22-2011 |
| 20110123522 | METHODS OF TREATING CANCER USING ANTI CD24 ANTIBODIES - Anti-CD24 antibodies and adjuvant combinations thereof with chemotherapeutic agents or toxins, which can be used to inhibit growth of CD24-expressing cancer cells and prevent and treat cancer are provided. | 05-26-2011 |
| 20110104225 | POLYPEPTIDES, MATRICES, HYDROGELS AND METHODS OF USING SAME FOR TISSUE REGENERATION AND REPAIR - A novel laminin polypeptide comprising the amino acid sequence set forth by SEQ ID NO:3 is disclosed. Also disclosed are compositions-of-matter comprising a polysaccharide (e.g., hyaluronic acid) and the novel laminin polypeptide; or hyaluronic acid, a laminin polypeptide and an antioxidant (e.g., superoxide dismutase), as well as matrices and hydrogels comprising same which can be used for ex vivo or in vivo tissue formation and for treatment of pathologies characterized by diseased, damaged or loss of tissue. | 05-05-2011 |
| 20100189750 | METHODS OF TREATING TUMORS IN IMMUNE-PRIVILEGED SITES - A method of treating cancer in an immune-privileged site of a subject in need thereof is provided. The method comprises systemically administering to an area outside the immune-privileged site of the subject, a therapeutically effective amount of naive, viable cells of a tumor of the subject, the tumor being in the immune-privileged site so as to generate an immune response in the subject, thereby treating the cancer in the immune-privileged site of the subject. | 07-29-2010 |
| 20100130587 | METHODS OF TREATING CANCER USING siRNA MOLECULES DIRECTED AGAINST CD24 - A method of treating a CD24-related medical condition is disclosed. The method comprises administering to a subject in need thereof at least one siRNA molecule selected from the group consisting of SEQ ID NO: 1 to 4. Pharmaceutical compositions comprising same are also disclosed. | 05-27-2010 |
